Sign in to view content

Impact of Intravitreal Anti-VEGF Therapy for Severe Non-Proliferative Diabetic Retinopathy (NPDR): Analyses Through a Monte-Carlo Simulation Model

Andrew A. Moshfeghi, MD, MBA, FASRS

Video
Published 2021

Related

DRCR.net Anti-VEGF Comparative Effectiveness Trial for Diabetic Macular Edema
Neil M. Bressler, MD
Member Podcasts
Interim Results of the Phase 1-2 PRISM Trial Evaluating 4D-150 a Dual-Transgene Intravitreal Genetic Medicine for Neovascular (Wet) Age-Related Macular Degeneration
Christine Kay, MD
Annual Meeting Talks
2023
Endophthalmitis After Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Inhibitors: Management and Visual Outcomes
Kunyong Xu, MD, MHSc
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more